Search

Your search keyword '"Iqbal, Tariq H"' showing total 220 results
Start Over Author "Iqbal, Tariq H"
220 results on '"Iqbal, Tariq H"'

3. A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease

Author

Saviano, Anella, Schettino, Anna, Iaccarino, Nunzia, Mansour, Adel Abo, Begum, Jenefa, Marigliano, Noemi, Raucci, Federica, Romano, Francesca, Riccardi, Gelsomina, Mitidieri, Emma, d'Emmanuele di Villa Bianca, Roberta, Bello, Ivana, Panza, Elisabetta, Smimmo, Martina, Vellecco, Valentina, Rimmer, Peter, Cheesbrough, Jonathan, Zhi, Zhaogong, Iqbal, Tariq H., Pieretti, Stefano, D'Amore, Vincenzo Maria, Marinelli, Luciana, La Pietra, Valeria, Sorrentino, Raffaella, Costa, Luisa, Caso, Francesco, Scarpa, Raffaele, Cirino, Giuseppe, Randazzo, Antonio, Bucci, Mariarosaria, McGettrick, Helen Michelle, Iqbal, Asif Jilani, and Maione, Francesco

Published
2024
Full Text
View/download PDF

4. The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Author

Mullish, Benjamin H, primary, Merrick, Blair, additional, Quraishi, Mohammed Nabil, additional, Bak, Aggie, additional, Green, Christopher A, additional, Moore, David J, additional, Porter, Robert J, additional, Elumogo, Ngozi T, additional, Segal, Jonathan P, additional, Sharma, Naveen, additional, Marsh, Belinda, additional, Kontkowski, Graziella, additional, Manzoor, Susan E, additional, Hart, Ailsa L, additional, Settle, Christopher, additional, Keller, Josbert J, additional, Hawkey, Peter, additional, Iqbal, Tariq H, additional, Goldenberg, Simon D, additional, and Williams, Horace R T, additional

Published
2024
Full Text
View/download PDF

5. Optimising triage of urgent referrals for suspected IBD: results from the Birmingham IBD inception study

Author

Rimmer, Peter, primary, Cheesbrough, Jonathan, additional, Harris, Jane, additional, Love, Melanie, additional, Tull, Samantha, additional, Iqbal, Asif, additional, Regan-Komito, Daniel, additional, Cooney, Rachel, additional, Hazel, Karl, additional, Sharma, Naveen, additional, Dietrich, Thomas, additional, Chapple, Iain, additional, Quraishi, Mohammad Nabil, additional, and Iqbal, Tariq H, additional

Published
2024
Full Text
View/download PDF

6. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

Author

Norton, Christine, Din, Shahida, Glatter, Jackie, Kammermeier, Jochen, Ramdeen, Madhoor, Quraishi, Nabil, Sagar, Peter, Radford, Shellie, Speight, R. Alexander, Steed, Helen, Mcfarlane, Michael, Hawthorne, A. Barney, Alexander, James L, Moran, Gordon W, Gaya, Daniel R, Raine, Tim, Hart, Ailsa, Kennedy, Nicholas A, Lindsay, James O, MacDonald, Jonathan, Segal, Jonathan P, Sebastian, Shaji, Selinger, Christian P, Parkes, Miles, Smith, Philip J, Dhar, Anjan, Subramanian, Sreedhar, Arasaradnam, Ramesh, Lamb, Christopher A, Ahmad, Tariq, Lees, Charlie W, Dobson, Liz, Wakeman, Ruth, Iqbal, Tariq H, Arnott, Ian, and Powell, Nick

Published
2021
Full Text
View/download PDF

7. The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey

Author

Baunwall, Simon Mark Dahl, Terveer, Elisabeth M, Dahlerup, Jens Frederik, Erikstrup, Christian, Arkkila, Perttu, Vehreschild, Maria JGT, Ianiro, Gianluca, Gasbarrini, Antonio, Sokol, Harry, Kump, Patrizia K, Satokari, Reetta, De Looze, Danny, Vermeire, Séverine, Nakov, Radislav, Brezina, Jan, Helms, Morten, Kjeldsen, Jens, Rode, Anne A, Kousgaard, Sabrina Just, Alric, Laurent, Trang-Poisson, Caroline, Scanzi, Julien, Link, Alexander, Stallmach, Andreas, Kupcinskas, Juozas, Johnsen, Peter Holger, Garborg, Kjetil, Rodríguez, Eugenia Sánchez, Serrander, Lena, Brummer, Robert J, Galpérine, Katerina Tatiana, Goldenberg, Simon D, Mullish, Benjamin H, Williams, Horace RT, Iqbal, Tariq H, Ponsioen, Cyriel, Kuijper, Ed J, Cammarota, Giovanni, Keller, Josbert J, and Hvas, Christian Lodberg

Published
2021
Full Text
View/download PDF

8. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Author

Patel, Vinod, Mazhar, Zia, Saich, Rebecca, Colleypriest, Ben, Tham, Tony C, Iqbal, Tariq H, Kaushik, Vishal, Murugesan, Senthil, Singh, Salil, Weaver, Sean, Preston, Cathryn, Butt, Assad, Smith, Melissa, Basude, Dharamveer, Beale, Amanda, Langlands, Sarah, Direkze, Natalie, Parkes, Miles, Torrente, Franco, De La Revella Negro, Juan, MacDonald, Chris Ewen, Evans, Stephen M, Gunasekera, Anton V J, Thakur, Alka, Elphick, David, Shenoy, Achuth, Nwokolo, Chuka U, Dhar, Anjan, Cole, Andrew T, Agrawal, Anurag, Bridger, Stephen, Doherty, Julie, Cooper, Sheldon C, de Silva, Shanika, Mowat, Craig, Mayhead, Phillip, Lees, Charlie, Jones, Gareth, Ahmad, Tariq, Hart, James W, Gaya, Daniel R, Russell, Richard K, Gervais, Lisa, Dunckley, Paul, Mahmood, Tariq, Banim, Paul J R, Sonwalkar, Sunil, Ghosh, Deb, Phillips, Rosemary H, Azaz, Amer, Sebastian, Shaji, Shenderey, Richard, Armstrong, Lawrence, Bell, Claire, Hariraj, Radhakrishnan, Matthews, Helen, Jafferbhoy, Hasnain, Selinger, Christian P, Zamvar, Veena, De Caestecker, John S, Willmott, Anne, Miller, Richard, Babu, Palani Sathish, Tzivinikos, Christos, Bloom, Stuart L, Chung-Faye, Guy, Croft, Nicholas M, Fell, John ME, Harbord, Marcus, Hart, Ailsa, Hope, Ben, Irving, Peter M, Lindsay, James O, Mawdsley, Joel E, McNair, Alistair, Monahan, Kevin J, Murray, Charles D, Orchard, Timothy, Paul, Thankam, Pollok, Richard, Shah, Neil, Bouri, Sonia, Johnson, Matt W, Modi, Anita, Kabiru, Kasamu Dawa, Baburajan, B K, Bhaduri, Bim, Fagbemi, Andrew Adebayo, Levison, Scott, Limdi, Jimmy K, Watts, Gill, Foley, Stephen, Ramadas, Arvind, MacFaul, George, Mansfield, John, Grellier, Leonie, Morris, Mary-Anne, Tremelling, Mark, Hawkey, Chris, Kirkham, Sian, Charlton, Charles PJ, Rodrigues, Astor, Simmons, Alison, Lewis, Stephen J, Snook, Jonathon, Tighe, Mark, Goggin, Patrick M, De Silva, Aminda N, Lal, Simon, Smith, Mark S, Panter, Simon, Cummings, J R Fraser, Dharmisari, Suranga, Carter, Martyn, Watts, David, Mahmood, Zahid, McLain, Bruce, Sen, Sandip, Pigott, Anna J, Hobday, David, Wesley, Emma, Johnston, Richard, Edwards, Cathryn, Beckly, John, Vani, Deven, Ramakrishnan, Subramaniam, Chaudhary, Rakesh, Trudgill, Nigel J, Cooney, Rachel, Bell, Andy, Prasad, Neeraj, Gordon, John N, Brookes, Matthew J, Li, Andy, Gore, Stephen, Kennedy, Nicholas A, Heap, Graham A, Green, Harry D, Hamilton, Benjamin, Bewshea, Claire, Walker, Gareth J, Thomas, Amanda, Nice, Rachel, Perry, Mandy H, Chanchlani, Neil, Heerasing, Neel M, Hendy, Peter, Lin, Simeng, Lees, Charlie W, Hart, Ailsa L, Mansfield, John C, Lindsay, James, McDonald, Timothy J, McGovern, Dermot, and Goodhand, James R

Published
2019
Full Text
View/download PDF

14. Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis.

Author

Zaman, Shafquat, Akingboye, Akinfemi, Mohamedahmed, Ali Yasen Y, Peterknecht, Elizabeth, Bhattacharya, Pratik, El-Asrag, Mohammed E, Iqbal, Tariq H, Quraishi, Mohammed Nabil, and Beggs, Andrew D

Abstract

Background The aim of this systematic review and meta-analysis is to assess the efficacy and safety of faecal microbiota transplantation [FMT] in the treatment of chronic pouchitis. Methods A PRISMA-compliant systematic review and meta-analysis was conducted using the following databases and clinical trial registers: Medline, Embase, Scopus, Cochrane Database of Systematic Reviews [CENTRAL], clinical trials.gov, ScienceDirect, and VHL [virtual health library]. The primary outcome was clinical response/remission in patients treated with FMT. Secondary outcomes included safety profile, quality of life, and changes in the gut microbiome. Results Seven observational cohort studies/case series and two randomised, controlled trials with a total of 103 patients were included. The route, preparation, and quantity of FMT administered varied among the included studies. Clinical response rate of 42.6% with a remission rate of 29.8% was estimated in our cohort following FMT therapy. Minor, self-limiting, adverse events were reported, and the treatment was well tolerated with good short- and long-term safety profiles. Successful FMT engraftment in recipients varied and, on average, microbial richness and diversity was lower in patients with pouchitis. In some instances, shifts with specific changes towards abundance of species, suggestive of a 'healthier' pouch microbiota, were observed following treatment with FMT. Conclusion The evidence for FMT in the treatment of chronic pouchitis is sparse, which limits any recommendations being made for its use in clinical practice. Current evidence from low-quality studies suggests a variable clinical response and remission rate, but the treatment is well tolerated, with a good safety profile. This review emphasises the need for rationally designed, well-powered, randomised, placebo-controlled trials to understand the efficacy of FMT for the treatment of pouchitis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Author

Lopetuso, Loris Riccardo, Deleu, Sara, Godny, Lihi, Petito, Valentina, Puca, Pierluigi, Facciotti, Federica, Sokol, Harry, Ianiro, Gianluca, Masucci, Luca, Abreu, Maria, Dotan, Iri, Costello, Samuel Paul, Hart, Ailsa, Iqbal, Tariq H, Paramsothy, Sudarshan, Sanguinetti, Maurizio, Danese, Silvio, Tilg, Herbert, Cominelli, Fabio, Pizarro, Theresa T, Armuzzi, Alessandro, Cammarota, Giovanni, Gasbarrini, Antonio, Vermeire, Séverine, Scaldaferri, Franco, Ianiro, Gianluca (ORCID:0000-0002-8318-0515), Masucci, Luca (ORCID:0000-0002-8358-6726), Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059), Armuzzi, Alessandro (ORCID:0000-0003-1572-0118), Cammarota, Giovanni (ORCID:0000-0002-3626-6148), Gasbarrini, Antonio (ORCID:0000-0002-7278-4823), Scaldaferri, Franco (ORCID:0000-0001-8334-7541), Lopetuso, Loris Riccardo, Deleu, Sara, Godny, Lihi, Petito, Valentina, Puca, Pierluigi, Facciotti, Federica, Sokol, Harry, Ianiro, Gianluca, Masucci, Luca, Abreu, Maria, Dotan, Iri, Costello, Samuel Paul, Hart, Ailsa, Iqbal, Tariq H, Paramsothy, Sudarshan, Sanguinetti, Maurizio, Danese, Silvio, Tilg, Herbert, Cominelli, Fabio, Pizarro, Theresa T, Armuzzi, Alessandro, Cammarota, Giovanni, Gasbarrini, Antonio, Vermeire, Séverine, Scaldaferri, Franco, Ianiro, Gianluca (ORCID:0000-0002-8318-0515), Masucci, Luca (ORCID:0000-0002-8358-6726), Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059), Armuzzi, Alessandro (ORCID:0000-0003-1572-0118), Cammarota, Giovanni (ORCID:0000-0002-3626-6148), Gasbarrini, Antonio (ORCID:0000-0002-7278-4823), and Scaldaferri, Franco (ORCID:0000-0001-8334-7541)

Abstract

Background: Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, have recently been published, but with major variations in study design. These include differences in administered dose, route and frequency of delivery, type of placebo and evaluated endpoints. Although the overall outcomes appear to be promising, they are highly dependent on both donor and recipient factors. Objective: To develop concensus-based statements and recommendations for the evaluation, management and potential treatment of IBD using FMT in order to move towards standardised practices. Design: An international panel of experts convened several times to generate evidence-based guidelines by performing a deep evaluation of currently available and/or published data. Twenty-five experts in IBD, immunology and microbiology collaborated in different working groups to provide statements on the following key issues related to FMT in IBD: (A) pathogenesis and rationale, (B) donor selection and biobanking, (C) FMT practices and (D) consideration of future studies and perspectives. Statements were evaluated and voted on by all members using an electronic Delphi process, culminating in a plenary consensus conference and generation of proposed guidelines. Results and conclusions: Our group has provided specific statements and recommendations, based on best available evidence, with the end goal of providing guidance and general criteria required to promote FMT as a recognised strategy for the treatment of IBD.

Published
2023

16. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Author

Mullish, Benjamin H, Merrick, Blair, Quraishi, Mohammed Nabil, Bak, Aggie, Green, Christopher A, Moore, David J, Porter, Robert J, Elumogo, Ngozi T, Segal, Jonathan P, Sharma, Naveen, Marsh, Belinda, Kontkowski, Graziella, Manzoor, Susan E, Hart, Ailsa L, Settle, Christopher, Keller, Josbert J, Hawkey, Peter, Iqbal, Tariq H, Goldenberg, Simon D, and Williams, Horace R T

Abstract

The first British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS)-endorsed faecal microbiota transplant (FMT) guidelines were published in 2018. Over the past 5 years, there has been considerable growth in the evidence base (including publication of outcomes from large national FMT registries), necessitating an updated critical review of the literature and a second edition of the BSG/HIS FMT guidelines. These have been produced in accordance with National Institute for Health and Care Excellence-accredited methodology, thus have particular relevance for UK-based clinicians, but are intended to be of pertinence internationally. This second edition of the guidelines have been divided into recommendations, good practice points and recommendations against certain practices. With respect to FMT for Clostridioides difficileinfection (CDI), key focus areas centred around timing of administration, increasing clinical experience of encapsulated FMT preparations and optimising donor screening. The latter topic is of particular relevance given the COVID-19 pandemic, and cases of patient morbidity and mortality resulting from FMT-related pathogen transmission. The guidelines also considered emergent literature on the use of FMT in non-CDI settings (including both gastrointestinal and non-gastrointestinal indications), reviewing relevant randomised controlled trials. Recommendations are provided regarding special areas (including compassionate FMT use), and considerations regarding the evolving landscape of FMT and microbiome therapeutics.

Published
2024
Full Text
View/download PDF

18. Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel

Author

Ianiro, Gianluca, primary, Mullish, Benjamin H, additional, Iqbal, Tariq H, additional, Terveer, Elisabeth M, additional, Baunwall, Simon Mark Dahl, additional, Link, Alexander, additional, Sokol, Harry, additional, Kupcinskas, Juozas, additional, Masucci, Luca, additional, Sanguinetti, Maurizio, additional, Vehreschild, Maria J G T, additional, Hvas, Christian L, additional, Keller, Josbert J, additional, Gasbarrini, Antonio, additional, Kujiper, Ed J, additional, and Cammarota, Giovanni, additional

Published
2022
Full Text
View/download PDF

23. O48 Novel interactions between bacterial strains and mucosal immune profiles after FMT for UC: STOP-colitis results

Author

Quraishi, Nabil, primary, Quince, Christopher, additional, Hewitt, Catherine, additional, Beggs, Andrew, additional, Gerasimidis, Konstantinos, additional, Sharma, Naveen, additional, Oo, Ye H, additional, Hawkey, Peter, additional, Ives, Natalie J, additional, Manzoor, Susan, additional, Loman, Nicholas, additional, Hansen, Richard, additional, Hart, Ailsa, additional, Gaya, Daniel, additional, and Iqbal, Tariq H, additional

Published
2022
Full Text
View/download PDF

24. Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel

Author

Ianiro, Gianluca, Mullish, Benjamin H, Iqbal, Tariq H, Terveer, Elisabeth M, Baunwall, Simon Mark Dahl, Link, Alexander, Sokol, Harry, Kupcinskas, Juoza, Masucci, Luca, Sanguinetti, Maurizio, Vehreschild, Maria J G T, Hvas, Christian L, Keller, Josbert J, Gasbarrini, Antonio, Kujiper, Ed J, Cammarota, Giovanni, Ianiro, Gianluca (ORCID:0000-0002-8318-0515), Masucci, Luca (ORCID:0000-0002-8358-6726), Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059), Gasbarrini, Antonio (ORCID:0000-0002-7278-4823), Cammarota, Giovanni (ORCID:0000-0002-3626-6148), Ianiro, Gianluca, Mullish, Benjamin H, Iqbal, Tariq H, Terveer, Elisabeth M, Baunwall, Simon Mark Dahl, Link, Alexander, Sokol, Harry, Kupcinskas, Juoza, Masucci, Luca, Sanguinetti, Maurizio, Vehreschild, Maria J G T, Hvas, Christian L, Keller, Josbert J, Gasbarrini, Antonio, Kujiper, Ed J, Cammarota, Giovanni, Ianiro, Gianluca (ORCID:0000-0002-8318-0515), Masucci, Luca (ORCID:0000-0002-8358-6726), Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059), Gasbarrini, Antonio (ORCID:0000-0002-7278-4823), and Cammarota, Giovanni (ORCID:0000-0002-3626-6148)

Abstract

N/A

Published
2022

26. SARS-CoV-2 vaccines and donor recruitment for FMT

Author

Ianiro, Gianluca, Mullish, Benjamin H, Hvas, Christian Lodberg, Segal, Jonathan P, Kuijper, Ed J, Costello, Samuel P, Kelly, Colleen R, Allegretti, Jessica R, Fischer, Monika, Iqbal, Tariq H, Satokari, Reetta, Kao, Dina, van Prehn, Joffrey, Ng, Siew C, Bibbò, Stefano, Baunwall, Simon Mark Dahl, Quraishi, Mohammed N, Sokol, Harry, Zhang, Faming, Keller, Josbert, Masucci, Luca, Quaranta, Gianluca, Kassam, Zain, Sanguinetti, Maurizio, Tilg, Herbert, Gasbarrini, Antonio, and Cammarota, Giovanni

Published
2021
Full Text
View/download PDF

28. The use of Faecal Microbiota Transplantation (FMT) in Europe:A Europe-wide survey

Author

Baunwall, Simon Mark Dahl, Terveer, Elisabeth M., Dahlerup, Jens Frederik, Erikstrup, Christian, Arkkila, Perttu, Vehreschild, Maria JGT, Ianiro, Gianluca, Gasbarrini, Antonio, Sokol, Harry, Kump, Patrizia K., Satokari, Reetta, De Looze, Danny, Vermeire, Séverine, Nakov, Radislav, Brezina, Jan, Helms, Morten, Kjeldsen, Jens, Rode, Anne A., Kousgaard, Sabrina Just, Alric, Laurent, Trang-Poisson, Caroline, Scanzi, Julien, Link, Alexander, Stallmach, Andreas, Kupcinskas, Juozas, Johnsen, Peter Holger, Garborg, Kjetil, Rodríguez, Eugenia Sánchez, Serrander, Lena, Brummer, Robert J., Galpérine, Katerina Tatiana, Goldenberg, Simon D., Mullish, Benjamin H., Williams, Horace RT, Iqbal, Tariq H., Ponsioen, Cyriel, Kuijper, Ed J., Cammarota, Giovanni, Keller, Josbert J., Hvas, Christian Lodberg, Baunwall, Simon Mark Dahl, Terveer, Elisabeth M., Dahlerup, Jens Frederik, Erikstrup, Christian, Arkkila, Perttu, Vehreschild, Maria JGT, Ianiro, Gianluca, Gasbarrini, Antonio, Sokol, Harry, Kump, Patrizia K., Satokari, Reetta, De Looze, Danny, Vermeire, Séverine, Nakov, Radislav, Brezina, Jan, Helms, Morten, Kjeldsen, Jens, Rode, Anne A., Kousgaard, Sabrina Just, Alric, Laurent, Trang-Poisson, Caroline, Scanzi, Julien, Link, Alexander, Stallmach, Andreas, Kupcinskas, Juozas, Johnsen, Peter Holger, Garborg, Kjetil, Rodríguez, Eugenia Sánchez, Serrander, Lena, Brummer, Robert J., Galpérine, Katerina Tatiana, Goldenberg, Simon D., Mullish, Benjamin H., Williams, Horace RT, Iqbal, Tariq H., Ponsioen, Cyriel, Kuijper, Ed J., Cammarota, Giovanni, Keller, Josbert J., and Hvas, Christian Lodberg

Abstract

Background: Faecal microbiota transplantation (FMT) is an emerging treatment modality, but its current clinical use and organisation are unknown. We aimed to describe the clinical use, conduct, and potential for FMT in Europe. Methods: We invited all hospital-based FMT centres within the European Council member states to answer a web-based questionnaire covering their clinical activities, organisation, and regulation of FMT in 2019. Responders were identified from trials registered at clinicaltrials.gov and from the United European Gastroenterology (UEG) working group for stool banking and FMT. Findings: In 2019, 31 FMT centres from 17 countries reported a total of 1,874 (median 25, quartile 10–64) FMT procedures; 1,077 (57%) with Clostridioides difficile infection (CDI) as indication, 791 (42%) with experimental indications, and 6 (0•3%) unaccounted for. Adjusted to population size, 0•257 per 100,000 population received FMT for CDI and 0•189 per 100,000 population for experimental indications. With estimated 12,400 (6,100–28,500) annual cases of multiple, recurrent CDI and indication for FMT in Europe, the current European FMT activity covers approximately 10% of the patients with indication. The participating centres demonstrated high safety standards and adherence to international consensus guidelines. Formal or informal regulation from health authorities was present at 21 (68%) centres. Interpretation: FMT is a widespread routine treatment for multiple, recurrent CDI and an experimental treatment. Embedded within hospital settings, FMT centres operate with high standards across Europe to provide safe FMT. A significant gap in FMT coverage suggests the need to raise clinical awareness and increase the FMT activity in Europe by at least 10-fold to meet the true, indicated need. Funding: NordForsk under the Nordic Council and Innovation Fund Denmark (j.no. 8056–00006B).

Published
2021

31. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

Author

Alexander, James L, primary, Moran, Gordon W, additional, Gaya, Daniel R, additional, Raine, Tim, additional, Hart, Ailsa, additional, Kennedy, Nicholas A, additional, Lindsay, James O, additional, MacDonald, Jonathan, additional, Segal, Jonathan P, additional, Sebastian, Shaji, additional, Selinger, Christian P, additional, Parkes, Miles, additional, Smith, Philip J, additional, Dhar, Anjan, additional, Subramanian, Sreedhar, additional, Arasaradnam, Ramesh, additional, Lamb, Christopher A, additional, Ahmad, Tariq, additional, Lees, Charlie W, additional, Dobson, Liz, additional, Wakeman, Ruth, additional, Iqbal, Tariq H, additional, Arnott, Ian, additional, Powell, Nick, additional, Norton, Christine, additional, Din, Shahida, additional, Glatter, Jackie, additional, Kammermeier, Jochen, additional, Ramdeen, Madhoor, additional, Quraishi, Nabil, additional, Sagar, Peter, additional, Radford, Shellie, additional, Speight, R. Alexander, additional, Steed, Helen, additional, Mcfarlane, Michael, additional, and Hawthorne, A. Barney, additional

Published
2021
Full Text
View/download PDF

32. O9 STOP-colitis pilot: prospective, open-label, randomised study comparing nasogastric versus colonic FMT delivery in ulcerative colitis

Author

Quraishi, Mohammed Nabil, primary, Yalchin, Mehmet, additional, Blackwell, Clare, additional, Segal, Jonathan, additional, Sharma, Naveen, additional, Hawkey, Peter, additional, McCune, Victoria, additional, Hewitt, Catherine, additional, Ives, Natalie J, additional, Loi, Shrushma, additional, Magill, Laura, additional, Manzoor, Susan, additional, Gerasimidis, Konstantinos, additional, Loman, Nicholas J, additional, McMullan, Christel, additional, Mathers, Jonathan, additional, Quince, Christopher, additional, Crees, Nicola, additional, Hansen, Richard, additional, Hart, Ailsa L, additional, Gaya, Daniel R, additional, and Iqbal, Tariq H, additional

Published
2021
Full Text
View/download PDF

33. P136 Immunomodulatory mechanisms of FMT is associated with clinical response in UC – results from STOP-Colitis

Author

Quraishi, Mohammed Nabil, primary, Oo, Ye, additional, Beggs, Andrew D, additional, Withers, David, additional, Acharjee, Animesh, additional, Sharma, Naveen, additional, Manzoor, Susan, additional, Loman, Nicholas J, additional, Gerasimidis, Konstantinos, additional, Hansen, Richard, additional, Gkoutous, Georgios, additional, Hart, Ailsa L, additional, Gaya, Daniel R, additional, and Iqbal, Tariq H, additional

Published
2021
Full Text
View/download PDF

37. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

Author

Ianiro, Gianluca, primary, Mullish, Benjamin H, additional, Kelly, Colleen R, additional, Kassam, Zain, additional, Kuijper, Ed J, additional, Ng, Siew C, additional, Iqbal, Tariq H, additional, Allegretti, Jessica R, additional, Bibbò, Stefano, additional, Sokol, Harry, additional, Zhang, Faming, additional, Fischer, Monika, additional, Costello, Samuel Paul, additional, Keller, Josbert J, additional, Masucci, Luca, additional, van Prehn, Joffrey, additional, Quaranta, Gianluca, additional, Quraishi, Mohammed Nabil, additional, Segal, Jonathan, additional, Kao, Dina, additional, Satokari, Reetta, additional, Sanguinetti, Maurizio, additional, Tilg, Herbert, additional, Gasbarrini, Antonio, additional, and Cammarota, Giovanni, additional

Published
2020
Full Text
View/download PDF

38. Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

Author

Kennedy, Nicholas A, primary, Hansen, Richard, additional, Younge, Lisa, additional, Mawdsley, Joel, additional, Beattie, R Mark, additional, Din, Shahida, additional, Lamb, Christopher A, additional, Smith, Philip J, additional, Selinger, Christian, additional, Limdi, Jimmy, additional, Iqbal, Tariq H, additional, Lobo, Alan, additional, Cooney, Rachel, additional, Brain, Oliver, additional, Gaya, Daniel R, additional, Murray, Charles, additional, Pollok, Richard, additional, Kent, Alexandra, additional, Raine, Tim, additional, Bhala, Neeraj, additional, Lindsay, James O, additional, Irving, Peter M, additional, Lees, Charlie W, additional, and Sebastian, Shaji, additional

Published
2020
Full Text
View/download PDF

41. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways

Author

Quraishi, Mohammed Nabil, primary, Acharjee, Animesh, additional, Beggs, Andrew D, additional, Horniblow, Richard, additional, Tselepis, Chris, additional, Gkoutos, Georgios, additional, Ghosh, Subrata, additional, Rossiter, A E, additional, Loman, Nicholas, additional, van Schaik, Willem, additional, Withers, David, additional, Walters, Julian R F, additional, Hirschfield, Gideon M, additional, and Iqbal, Tariq H, additional

Published
2020
Full Text
View/download PDF

42. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Author

Sazonovs, Aleksejs, primary, Kennedy, Nicholas A., additional, Moutsianas, Loukas, additional, Heap, Graham A., additional, Rice, Daniel L., additional, Reppell, Mark, additional, Bewshea, Claire M., additional, Chanchlani, Neil, additional, Walker, Gareth J., additional, Perry, Mandy H., additional, McDonald, Timothy J., additional, Lees, Charlie W., additional, Cummings, J.R. Fraser, additional, Parkes, Miles, additional, Mansfield, John C., additional, Irving, Peter M., additional, Barrett, Jeffrey C., additional, McGovern, Dermot, additional, Goodhand, James R., additional, Anderson, Carl A., additional, Ahmad, Tariq, additional, Patel, Vinod, additional, Mazhar, Zia, additional, Saich, Rebecca, additional, Colleypriest, Ben, additional, Tham, Tony C, additional, Iqbal, Tariq H, additional, Kaushik, Vishal, additional, Murugesan, Senthil, additional, Singh, Salil, additional, Weaver, Sean, additional, Preston, Cathryn, additional, Butt, Assad, additional, Smith, Melissa, additional, Basude, Dharamveer, additional, Beale, Amanda, additional, Langlands, Sarah, additional, Direkze, Natalie, additional, Torrente, Franco, additional, De La Revella Negro, Juan, additional, Ewen MacDonald, Chris, additional, Evans, Stephen M, additional, Gunasekera, Anton V J, additional, Thakur, Alka, additional, Elphick, David, additional, Shenoy, Achuth, additional, Nwokolo, Chuka U, additional, Dhar, Anjan, additional, Cole, Andrew T, additional, Agrawal, Anurag, additional, Bridger, Stephen, additional, Doherty, Julie, additional, Cooper, Sheldon C, additional, de Silva, Shanika, additional, Mowat, Craig, additional, Mayhead, Phillip, additional, Lees, Charlie, additional, Jones, Gareth, additional, Hart, James W, additional, Gaya, Daniel R, additional, Russell, Richard K, additional, Gervais, Lisa, additional, Dunckley, Paul, additional, Mahmood, Tariq, additional, Banim, Paul J R, additional, Sonwalkar, Sunil, additional, Ghosh, Deb, additional, Phillips, Rosemary H, additional, Azaz, Amer, additional, Sebastian, Shaji, additional, Shenderey, Richard, additional, Armstrong, Lawrence, additional, Bell, Claire, additional, Hariraj, Radhakrishnan, additional, Matthews, Helen, additional, Jafferbhoy, Hasnain, additional, Selinger, Christian P, additional, Zamvar, Veena, additional, De Caestecker, John S, additional, Willmott, Anne, additional, Miller, Richard, additional, Sathish Babu, Palani, additional, Tzivinikos, Christos, additional, Bloom, Stuart L, additional, Chung-Faye, Guy, additional, Croft, Nicholas M, additional, Fell, John ME, additional, Harbord, Marcus, additional, Hart, Ailsa, additional, Hope, Ben, additional, Irving, Peter M, additional, Lindsay, James O, additional, Mawdsley, Joel E, additional, McNair, Alistair, additional, Monahan, Kevin J, additional, Murray, Charles D, additional, Orchard, Timothy, additional, Paul, Thankam, additional, Pollok, Richard, additional, Shah, Neil, additional, Bouri, Sonia, additional, Johnson, Matt W, additional, Modi, Anita, additional, Dawa Kabiru, Kasamu, additional, Baburajan, B K, additional, Bhaduri, Bim, additional, Adebayo Fagbemi, Andrew, additional, Levison, Scott, additional, Limdi, Jimmy K, additional, Watts, Gill, additional, Foley, Stephen, additional, Ramadas, Arvind, additional, MacFaul, George, additional, Mansfield, John, additional, Grellier, Leonie, additional, Morris, Mary-Anne, additional, Tremelling, Mark, additional, Hawkey, Chris, additional, Kirkham, Sian, additional, Charlton, Charles PJ, additional, Rodrigues, Astor, additional, Simmons, Alison, additional, Lewis, Stephen J, additional, Snook, Jonathon, additional, Tighe, Mark, additional, Goggin, Patrick M, additional, De Silva, Aminda N, additional, Lal, Simon, additional, Smith, Mark S, additional, Panter, Simon, additional, Cummings, Fraser, additional, Dharmisari, Suranga, additional, Carter, Martyn, additional, Watts, David, additional, Mahmood, Zahid, additional, McLain, Bruce, additional, Sen, Sandip, additional, Pigott, Anna J, additional, Hobday, David, additional, Wesley, Emma, additional, Johnston, Richard, additional, Edwards, Cathryn, additional, Beckly, John, additional, Vani, Deven, additional, Ramakrishnan, Subramaniam, additional, Chaudhary, Rakesh, additional, Trudgill, Nigel J, additional, Cooney, Rachel, additional, Bell, Andy, additional, Prasad, Neeraj, additional, Gordon, John N, additional, Brookes, Matthew J, additional, Li, Andy, additional, and Gore, Stephen, additional

Published
2020
Full Text
View/download PDF

47. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Author

Kennedy, Nicholas A, primary, Heap, Graham A, additional, Green, Harry D, additional, Hamilton, Benjamin, additional, Bewshea, Claire, additional, Walker, Gareth J, additional, Thomas, Amanda, additional, Nice, Rachel, additional, Perry, Mandy H, additional, Bouri, Sonia, additional, Chanchlani, Neil, additional, Heerasing, Neel M, additional, Hendy, Peter, additional, Lin, Simeng, additional, Gaya, Daniel R, additional, Cummings, J R Fraser, additional, Selinger, Christian P, additional, Lees, Charlie W, additional, Hart, Ailsa L, additional, Parkes, Miles, additional, Sebastian, Shaji, additional, Mansfield, John C, additional, Irving, Peter M, additional, Lindsay, James, additional, Russell, Richard K, additional, McDonald, Timothy J, additional, McGovern, Dermot, additional, Goodhand, James R, additional, Ahmad, Tariq, additional, Patel, Vinod, additional, Mazhar, Zia, additional, Saich, Rebecca, additional, Colleypriest, Ben, additional, Tham, Tony C, additional, Iqbal, Tariq H, additional, Kaushik, Vishal, additional, Murugesan, Senthil, additional, Singh, Salil, additional, Weaver, Sean, additional, Preston, Cathryn, additional, Butt, Assad, additional, Smith, Melissa, additional, Basude, Dharamveer, additional, Beale, Amanda, additional, Langlands, Sarah, additional, Direkze, Natalie, additional, Torrente, Franco, additional, De La Revella Negro, Juan, additional, MacDonald, Chris Ewen, additional, Evans, Stephen M, additional, Gunasekera, Anton V J, additional, Thakur, Alka, additional, Elphick, David, additional, Shenoy, Achuth, additional, Nwokolo, Chuka U, additional, Dhar, Anjan, additional, Cole, Andrew T, additional, Agrawal, Anurag, additional, Bridger, Stephen, additional, Doherty, Julie, additional, Cooper, Sheldon C, additional, de Silva, Shanika, additional, Mowat, Craig, additional, Mayhead, Phillip, additional, Lees, Charlie, additional, Jones, Gareth, additional, Hart, James W, additional, Gervais, Lisa, additional, Dunckley, Paul, additional, Mahmood, Tariq, additional, Banim, Paul J R, additional, Sonwalkar, Sunil, additional, Ghosh, Deb, additional, Phillips, Rosemary H, additional, Azaz, Amer, additional, Shenderey, Richard, additional, Armstrong, Lawrence, additional, Bell, Claire, additional, Hariraj, Radhakrishnan, additional, Matthews, Helen, additional, Jafferbhoy, Hasnain, additional, Zamvar, Veena, additional, De Caestecker, John S, additional, Willmott, Anne, additional, Miller, Richard, additional, Babu, Palani Sathish, additional, Tzivinikos, Christos, additional, Bloom, Stuart L, additional, Chung-Faye, Guy, additional, Croft, Nicholas M, additional, Fell, John ME, additional, Harbord, Marcus, additional, Hart, Ailsa, additional, Hope, Ben, additional, Lindsay, James O, additional, Mawdsley, Joel E, additional, McNair, Alistair, additional, Monahan, Kevin J, additional, Murray, Charles D, additional, Orchard, Timothy, additional, Paul, Thankam, additional, Pollok, Richard, additional, Shah, Neil, additional, Johnson, Matt W, additional, Modi, Anita, additional, Kabiru, Kasamu Dawa, additional, Baburajan, B K, additional, Bhaduri, Bim, additional, Fagbemi, Andrew Adebayo, additional, Levison, Scott, additional, Limdi, Jimmy K, additional, Watts, Gill, additional, Foley, Stephen, additional, Ramadas, Arvind, additional, MacFaul, George, additional, Mansfield, John, additional, Grellier, Leonie, additional, Morris, Mary-Anne, additional, Tremelling, Mark, additional, Hawkey, Chris, additional, Kirkham, Sian, additional, Charlton, Charles PJ, additional, Rodrigues, Astor, additional, Simmons, Alison, additional, Lewis, Stephen J, additional, Snook, Jonathon, additional, Tighe, Mark, additional, Goggin, Patrick M, additional, De Silva, Aminda N, additional, Lal, Simon, additional, Smith, Mark S, additional, Panter, Simon, additional, Dharmisari, Suranga, additional, Carter, Martyn, additional, Watts, David, additional, Mahmood, Zahid, additional, McLain, Bruce, additional, Sen, Sandip, additional, Pigott, Anna J, additional, Hobday, David, additional, Wesley, Emma, additional, Johnston, Richard, additional, Edwards, Cathryn, additional, Beckly, John, additional, Vani, Deven, additional, Ramakrishnan, Subramaniam, additional, Chaudhary, Rakesh, additional, Trudgill, Nigel J, additional, Cooney, Rachel, additional, Bell, Andy, additional, Prasad, Neeraj, additional, Gordon, John N, additional, Brookes, Matthew J, additional, Li, Andy, additional, and Gore, Stephen, additional

Published
2019
Full Text
View/download PDF

50. Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.

Author

Aksan, Ayşegül, Wohlrath, M, Iqbal, Tariq H, Dignass, A, and Stein, J

Abstract

Background and Aims Anaemia is common in patients with inflammatory bowel disease [IBD], its two main aetiologies being iron deficiency anaemia [IDA] and anaemia of chronic inflammation [ACI]. Impaired intestinal iron absorption due to inflammatory cytokines is thought to play a role in ACI. We undertook for the first time a controlled prospective study investigating effects of differing underlying diseases, disease locations, and types of iron deficiency or anaemia on oral iron absorption in adult IBD patients with and without inflammation. Methods This study was a comparative, single-centred open clinical trial in adults with IBD [ n = 73] and healthy controls [ n = 22]. Baseline parameters included blood count, iron status [ferritin, transferrin, transferrin saturation, soluble transferrin receptor, hepcidin, serum iron], high-sensitivity C-reactive protein [hsCRP] and interleukin-6. Iron absorption was tested using one oral, enteric-coated capsule containing 567.7 mg iron[II]-glycine-sulphate complex. Serum iron was determined 60/90/120/180/240 min after ingestion. Results Iron absorption capacity was shown to be influenced by inflammation and anaemia or iron deficiency [ID] type but not by underlying disease type or localisation. The ACI group showed a significantly lower iron absorption capacity than all others. Whereas hsCRP levels [-0.387, p < 0.001], IL-6 [-0.331, p = 0.006], ferritin [-0.531, p < 0.001], and serum hepcidin [-0.353, p = 0.003] correlated negatively with serum iron change at 2 h, transferrin showed a positive correlation at the same time point [0.379, p < 0.001]. Conclusions Underlying disease type and localisation appear to have little effect on iron absorption capacity, whereas lack of response to oral iron correlates well with serum markers of inflammation. Iron absorption capacity is thus significantly reduced in the presence of inflammation. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results